首页 > 市场调查报告书 > 医疗设备

麻醉

市场调查报告书

商品编码

1374841

全球麻醉蒸发器市场 - 2023-2030

Global Anaesthesia Vaporizer Market - 2023-2030

出版日期: 2023年11月01日 | 出版商:

DataM Intelligence | 英文 175 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

麻醉蒸发器用于蒸发液体麻醉剂并向患者输送受控量的麻醉剂。有三种类型的浓度校准蒸发器可变旁路、加热混合器和电子控制蒸汽盒。这些设备用于手术室、急诊室、产房、创伤科、门诊手术中心以及任何需要吸入剂的区域。在绝大多数情况下，蒸发器将安装在麻醉机上；然而，汽化器也可以透过使用特殊的安装块与心肺旁路控制台相关联。

蒸发器是麻醉设备的重要组成部分。为了确保充分使用这些设备，需要了解生理学和物理学。及时识别蒸发器功能问题也很重要，因为这将减少患者可能暴露于轻度麻醉和疼痛的时间。

市场动态：驱动因素与限制因素

科技进步的崛起

麻醉蒸发器技术的进步（例如精确剂量和安全功能）吸引了医疗保健提供者升级其设备。许多进步已经发布，有助于市场在预测期内的成长。例如，整合到 Zeus 麻醉机中的 Drager DIVA 蒸发器可透过闭环定量控制氧气、载气和麻醉蒸汽的输送来实现目标控制麻醉。

此外，手术数量的增加、医院和诊所数量的增加、老年人口的增长以及高医疗保健支出等因素推动了市场的成长。新兴国家麻醉蒸发面罩市场需求的增加以及手术设备领域的研发预计将在预测期内创造新的机会。

市场动态：克制

产品召回可能会对麻醉蒸发器市场产生重大影响，因为它们可能导致消费者信心丧失和销售下降。它们也可能给製造商带来法律和财务后果。

例如，2021 年 12 月，Getinge 宣布在全球召回与 Flow Family 麻醉系统的特定七氟烷蒸发器相关的医疗设备。迄今为止，尚未报告患者或操作者发生不良事件。 Getinge 已根据适用法规向相关当局报告，目前正在透过现场安全通知/召回的方式向受影响的客户通报该问题。此外，设备的高成本和监管挑战将进一步阻碍预测期内的市场成长率。

Anesthesia vaporizers are used to vaporize a liquid anaesthetic agent and deliver a controlled amount to the patient. There are three types of concentration-calibrated vaporisers variable bypass, heated blender, and electronically controlled vapor cassettes. These devices are used in operating rooms, emergency departments, delivery rooms, trauma departments, ambulatory surgical centres, and any areas requiring the administration of an inhalation agent. In the vast majority of cases, vaporizers will be mounted on anaesthesia machines; however, vaporizers can also be associated with cardiopulmonary bypass consoles by the use of special mounting blocks.

Vaporizers are an important part of anesthesia equipment. An understanding of physiology and physics is warranted to ensure the adequate use of these devices. The timely recognition of problems in vaporizer functioning is also essential, as this will decrease the amount of time that patients are potentially exposed to light anesthesia and pain.

Market Dynamics: Drivers and Restraints

Rise in the technological advancements

The rise in the advancements in anaesthesia vaporizer technology, such as precision dosing and safety features, attracts healthcare providers to upgrade their equipment. Many advancements have been released where it helps the market to grow during the forecast period. For example, The Drager DIVA vaporiser which is integrated into the Zeus anaesthesia machine allows for target-controlled anaesthesia with closed-loop quantitative control of the delivery of oxygen, carrier gas and anaesthetic vapour.

Furthermore, factors such as an increase in the number of surgeries, a rise in a number of hospitals and clinics, growth in the geriatric population, and high healthcare expenditure drive the market growth. The increase in demand for anesthesia vaporizer masks market in emerging nations and R&D in the field of surgical equipment is anticipated to create new opportunities during the forecast period.

Market Dynamics: Restraint

Product recalls can have a significant impact on the anesthesia vaporizer market, as they can lead to a loss of consumer confidence and a decrease in sales. They can also result in legal and financial consequences for the manufacturers.

For instance, in December 2021, Getinge stated a global medical device recall related to specific Sevoflurane vaporizers for Flow Family Anesthesia systems. To date, no patient or operator adverse events have been reported. Getinge has reported to relevant authorities according to applicable regulations and is now informing affected customers about the issue through a field safety notice/recall. Also high cost of devices, and regulatory challenges will further hamper the market growth rate during the forecast period.

Segment Analysis

The global anaesthesia vaporizer is segmented based on product type, agent-specific, end-user and region.

The Plenum Vaporizers from the product type segment accounted for approximately 41.2% of the market share

The plenum vaporizers from the product type segment accounted for approximately 41.2% and it is expected to be dominated during the forecast period. Plenum vaporizers are characterized by a pressurized vaporization chamber that generates an increased internal resistance (above atmospheric pressure) for fresh gas flow.

This type of vaporizer is currently the most commonly used and is characterized by its accuracy in the mixture of gases provided to the patient. It is not temperature-compensated. When the control knob, which is just a crude split ratio controller, is in the down position, the cowling over the U-tube descends and brings the FGF closer to the surface of the agent or forces it to bubble through the ether, increasing output by increasing the gas/liquid interface.

Geographical Analysis

North America accounted for approximately 38.4% of the market share in 2022

North America is estimated to hold about 38.4% of the total market share throughout the forecast period, owing to the strategic partnerships with key players, improved healthcare infrastructure, product launches by key players and others that will help this region to grow during the forecast period.

For instance, in April 2022, Respirair and Dechra confirmed the US Veterinary Anesthesia Partnership in the USA for isoflurane and sevoflurane veterinary vaporizers and anesthesia accessories. By supplying its market-leading, precision-engineered vaporizers, trolleys and accessories, in conjunction with Dechra's isoflurane and sevoflurane general inhalation anaesthetic agents, the collaboration seeks to create a powerful new force in veterinary anaesthesia coupled with proven, trusted and peerless quality delivery technologies.

COVID-19 Impact Analysis

COVID-19 had a substantial impact on the global anaesthesia vaporizer market and the COVID-19 pandemic has led to an increased demand for healthcare services, including surgeries and medical procedures, which has boosted the performance of the healthcare sector.

Also, during the pandemic over 20% of coronavirus victims suffered from acute respiratory distress syndrome needing lifesaving therapies in ICUs which led to enormous resource and infrastructure challenges. However, the crisis arguably created the perfect incubator for new ideas and accelerated innovation in anaesthesia vaporizers which helped the market to grow during the forecast period.

Market Segmentation

By Product Type

Plenum Vaporizers
Drawover Vaporizers
Tec3 Vaporizers

By Agent Specific

Single Agent
Multiple Agents

By End User

Hospitals
Clinics
Ambulatory Surgical Centers
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Competitive Landscape

The major global players in the anaesthesia vaporizer market include: GE Healthcare, Medline, Nanjing Chenwei Medical Equipment Co., Ltd., Dolphinmed, Conduct Science, Penlon, Dragerwerk AG & Co. KGaA, iClearhealthcare, Alnoor Medical, Harvard Apparatus and among others.

Key Developments

In April 2022, GE Healthcare stated that the FDA pre-market approval (PMA) for its End-tidal (Et) Control software for general anesthesia delivery on its Aisys CS2 Anesthesia Delivery System. GE Healthcare is the only manufacturer approved to offer general anaesthesia delivery with end-tidal concentration control in the U.S. The company initially released the technology in Europe in 2010 and anesthesia providers use Et Control software to care for patients in over 100 countries.

Why Purchase the Report?

To visualize the global anaesthesia vaporizer market segmentation-based product type, agent-specific, end-user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development
Excel data sheet with numerous data points of anaesthesia vaporizer market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global anaesthesia vaporizer market report would provide approximately 61 tables, 57 figures, and 175 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Agent Specific
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Driver
  - 4.1.1.1. Rise in the technology advancements
  - 4.1.1.2. Rise in the geriatric population
- 4.1.2. Restraints
  - 4.1.2.1. Product Recalls
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
7.2. Plenum Vaporizers *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Drawover Vaporizers
7.4. Tec3 Vaporizers

8. By Agent Specific

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Agent Specific
- 8.1.2. Market Attractiveness Index, By Agent Specific
8.2. Single Agent *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Multiple Agents

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Clinics
9.4. Ambulatory Surgical Centers
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Agent Specific
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Agent Specific
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. UK
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Spain
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Agent Specific
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Agent Specific
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Agent Specific
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. GE Healthcare
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Medline
12.3. NANJING CHENWEI MEDICAL EQUIPMENT CO., LTD.
12.4. Dolphinmed
12.5. Conduct Science
12.6. Penlon
12.7. Dragerwerk AG & Co. KGaA
12.8. iClearhealthcare
12.9. Alnoor Medical
12.10. Harvard Apparatus

LIST NOT EXHAUSTIVE